Operating Margin of Tarsus Pharmaceuticals, Inc. from 31 Mar 2021 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Summary
-
Tarsus Pharmaceuticals, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Mar 2021 to 31 Dec 2025.
- Tarsus Pharmaceuticals, Inc. Operating Margin for the quarter ending 31 Dec 2025 was -16%, a 76% increase year-over-year.
- Tarsus Pharmaceuticals, Inc. annual Operating Margin for 2025 was -16%, a 76% increase from 2024.
- Tarsus Pharmaceuticals, Inc. annual Operating Margin for 2024 was -66%, a 92% increase from 2023.
- Tarsus Pharmaceuticals, Inc. annual Operating Margin for 2023 was -821%, a 238% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
Tarsus Pharmaceuticals, Inc. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -16% | +50% | +76% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -24% | +85% | +78% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -33% | +154% | +82% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -47% | +320% | +87% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -66% | +755% | +92% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -108% | +683% | +86% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -188% | +578% | +76% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -366% | -121% | -49% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -821% | -578% | -238% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -792% | -407% | -106% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -766% | -450% | -143% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -245% | -70% | -40% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -243% | -222% | -1040% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -384% | -368% | -2273% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -316% | -309% | -4733% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -176% | -133% | -315% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -21% | 01 Oct 2021 | 31 Dec 2021 | ||
| Q3 2021 | -16% | 01 Jul 2021 | 30 Sep 2021 | ||
| Q2 2021 | -6.5% | 01 Apr 2021 | 30 Jun 2021 | ||
| Q1 2021 | -42% | 01 Jan 2021 | 31 Mar 2021 |
Tarsus Pharmaceuticals, Inc. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -16% | +50% | +76% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -66% | +755% | +92% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | -821% | -578% | -238% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -243% | -222% | -1040% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -21% | 01 Jan 2021 | 31 Dec 2021 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.